BioSpace News Archive

Drug Development

Initial Data from Allarity’s Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical Benefit in DRP®-Selected Metastatic Breast Cancer Patients

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (Nasdaq: ALLR) today announced initial results from its European Phase 2 clinical trial evaluating the efficacy of IXEMPRA® in metastatic breast cancer (mBC) patients selected with the DRP®-IXEMPRA® companion diagnostic (CDx) candidate.

July 5, 2023
·
9 min read
Building a Vertically Integrated Diagnostics Powerhouse: EDP Biotech Corp. and New Day Diagnostics, LLC Announce Asset Merger

EDP Biotech Corp. (EDP Biotech) and New Day Diagnostics, LLC (New Day Diagnostics) are pleased to announce their combination, forming a vertically integrated force in the expedited development and commercialization of diagnostic tests.

July 5, 2023
·
4 min read
Business

Defence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnology

Defence Therapeutics Inc. (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce its collaboration with Viewpoint with Dennis Quaid.

July 5, 2023
·
4 min read
Deals

Awakn Life Sciences Completes Sale of Awakn Clinics London

Licenses Awakn Kare and Certain Healthcare Intellectual Property Assets to New Owners

July 5, 2023
·
5 min read
Business

Sirnaomics Establishes a Strategic Partnership with EDIRNA Inc., an RNA-Editing Therapeutic Company

Sirnaomics Ltd. announced that the Company has established a strategic partnership with EDIRNA Inc., an early-stage biotech company focused on RNA-Editing therapeutic company, for advancing its proprietary “Edit-to-Cure Therapeutics™" platform, targeting diseases with high unmet clinical need.

July 5, 2023
·
3 min read
Poxel, winner of the 2023 edition of the I-nov contest

POXEL SA announces to be the winner of the 2023 edition of the I-nov contest for its program in adrenoleukodystrophy, a rare neurometabolic disease, for which there is currently no treatment.

July 5, 2023
·
5 min read
BioMidwest

Inspired Spine Hosts Third International Lab in Germany, Showcasing OLLIF and Trident SI Joint Fusion Procedures

Inspired Spine, a global leader in minimally invasive spinal surgery, hosted their Trans Kambin OLLIF lab Monday July 3rd at Sana Regio Pinneberg Klinikum in Pinneberg Germany.

July 5, 2023
·
2 min read
BioForest

ISSRDC Session to Focus on Advancing Cardiovascular Research in Low Earth Orbit

A fireside chat with space station researcher Arun Sharma at the 12th annual International Space Station Research and Development Conference (ISSRDC) will highlight cardiovascular research in low Earth orbit (LEO).

July 5, 2023
·
3 min read
Business

Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer

Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, today announced that Matthew Lang, J.D. has joined the executive management team as Chief Business Officer.

July 5, 2023
·
3 min read
Business

Venus Concept to Release Second Quarter of Fiscal Year 2023 Financial Results on August 14, 2023

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2023 financial results will be released after the market closes on Monday, August 14, 2023.

July 5, 2023
·
1 min read